Memory and motor deficits are commonly identified in Parkinson's disease (PD). 1-Methyl-4-
phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) is transformed to MPP+ via monoamine oxidase …

Parkinson's disease (PD) is the second most common neurodegenerative disorder affecting
about 1% of the population older than 60 years. Classically, PD is considered as a …

Background Systemic inflammation might cause neuronal damage and sustain
neurodegenerative diseases and behavior impairment, with the participation of pro …

Depression is highly prevalent worldwide and associated with significant morbidity and
mortality. Approximately 340 million people worldwide suffer from depression at any given …

Animal models for learning and memory have significantly contributed to novel strategies for
drug development and hence are an imperative part in the assessment of therapeutics …

Neuregulins (NRGs) are a family of epidermal growth factor-related proteins, acting on
tyrosine kinase receptors of the ErbB family. NRGs play an essential role in the development …

Objective: Neuroinflammation contributes to the development and progression of
Parkinson's disease (PD). The aim of this study was to examine whether ultrasound (US) …

Humans are increasingly and consistently exposed to a variety of endocrine disrupting
chemicals (EDCs), chemicals that have been linked to neurobehavioral disorders such as …

Besides the hallmark motor symptoms (rest tremor, hypokinesia, rigidity, and postural
instability), patients with Parkinson's disease (PD) have non-motor symptoms, namely …

Parkinson's disease (PD) has been, until recently, mainly defined by the presence of
characteristic motor symptoms, such as rigidity, tremor, bradykinesia/akinesia, and postural …